GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procter & Gamble Health Ltd (BOM:500126) » Definitions » Equity-to-Asset

Procter & Gamble Health (BOM:500126) Equity-to-Asset : 0.00 (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Procter & Gamble Health Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Procter & Gamble Health's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹0 Mil. Procter & Gamble Health's Total Assets for the quarter that ended in Mar. 2024 was ₹0 Mil.

The historical rank and industry rank for Procter & Gamble Health's Equity-to-Asset or its related term are showing as below:

BOM:500126' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.68   Med: 0.75   Max: 0.88
Current: 0.75

During the past 13 years, the highest Equity to Asset Ratio of Procter & Gamble Health was 0.88. The lowest was 0.68. And the median was 0.75.

BOM:500126's Equity-to-Asset is ranked better than
74.82% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs BOM:500126: 0.75

Procter & Gamble Health Equity-to-Asset Historical Data

The historical data trend for Procter & Gamble Health's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procter & Gamble Health Equity-to-Asset Chart

Procter & Gamble Health Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Jun21 Jun22 Jun23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 0.88 0.71 0.69 0.68

Procter & Gamble Health Quarterly Data
Mar19 Jun19 Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.68 - 0.75 -

Competitive Comparison of Procter & Gamble Health's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Procter & Gamble Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Procter & Gamble Health's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procter & Gamble Health's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Procter & Gamble Health's Equity-to-Asset falls into.



Procter & Gamble Health Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Procter & Gamble Health's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Equity to Asset (A: Jun. 2023 )=Total Stockholders Equity/Total Assets
=7508.9/11011.9
=0.68

Procter & Gamble Health's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=0/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Procter & Gamble Health  (BOM:500126) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Procter & Gamble Health Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Procter & Gamble Health's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Procter & Gamble Health (BOM:500126) Business Description

Traded in Other Exchanges
Address
Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.

Procter & Gamble Health (BOM:500126) Headlines

No Headlines